Stock comparison
Side-by-side financials for BSEM and GILD. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
GILD is larger
Market cap data is available for the leading company in this comparison.
Market value leader
GILD
Latest market capitalization comparison.
Revenue leader
GILD
BSEM: $47.48M vs GILD: $29.44B.
Profit leader
GILD
BSEM: -$6.58M vs GILD: $8.51B.
Margin leader
GILD
BSEM: -13.9% vs GILD: 28.9% net margin.
| Metric | BSEM | GILD |
|---|---|---|
| Market cap | - | $207.63 B |
| US-listed rank | - | #65 |
| Revenue (latest FY) | $47.48M | $29.44B |
| Net income (latest FY) | -$6.58M | $8.51B |
| Net margin | -13.9% | 28.9% |
| P/E (trailing FY) | - | 24.4x |
| SEC filings | 73 | 1,000 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, BIOSTEM TECHNOLOGIES reported $47.48M in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: BIOSTEM TECHNOLOGIES and GILEAD SCIENCES, INC., or browse the full rankings.